investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Use of DND1 to counteract miRNA function in cancers
Angabin Matin
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Angabin Matin
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Jonathan Ashwell
T Cell Alternative p38 Activation Pathway – Rockville
Pancreas
Pathology
Kathleen M Mulder
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells
Pancreas
Pathology
Channing J Der
Identification of synthetic lethal interactors in pancreatic cancer
Pancreas
Pathology
Jonathan R Pollack
Mechanisms and targeting of SWI/SNF alterations in pancreatic cancer
Pancreas
Pathology
Frank Gonzalez
Xenobiotic Receptors
Pancreas
Marilyn D Resh
Hedgehog Acyltransferase as a target in cancer
Pancreas
Alec Kimmelman
Investigating a Novel Glutamine Metabolism Pathway in Pancreatic Cancer
Pancreas
Keping Xie
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation
Pancreas
Pathology
Keping Xie
Functional Validation of Pancreatic Cancer Progression Biomarker
Pancreas
Pathology